Neurological soft signs in schizophrenia: Assessment and correlates

  • F. Mohr
  • W. Hubmann
  • W. Bender
  • S. Hönicke
  • Ch. Wahlheim
  • R. Cohen
  • C. Haslacher
  • R. Schlenker
  • P. Werther
Original Paper


A German version of the Neurological Evaluation Scale (NES) was administered to 143 schizophrenic patients, 45 of them being severly chronic and disabled. Seventy-eight alcohol-dependent inpatients and 57 healthy volunteers were tested as control groups. Neurological soft signs (NSS) were rated with convincing agreement. Schizophrenic patients are more impaired on all scales than healthy controls. The chronic, severly disabled schizophrenic patients are more impaired compared with the main group of schizophrenic patients and both control groups. A significant patients and alcohol-dependent patients was only found for the subscale “Motor Coordination”. Compared with healthy controls the alcohol-dependent patients show a higher NES total score. The NES total score was related to the relative width of the third ventricle. Total score and subscales were correlated consistently with the level of cognitive functioning as measured by the Raven Standard Progressive Matrices and various neuropsychological tests presumably sensitive to dysfunctions of the prefrontal cortex. The NSS were related to positive as well as to negative symptoms, the correlations with negative symptoms being confined to items of “Cognitive Disorganization”. This close association of psychomotor and cognitive dysfunctions may be seen as related to the frequently discussed dysfunctions of the prefrontal cortex or the neurointegrative deficit postulated by Meehl.

Key words

Schizophrenia Alcohol-dependent patients Neurological soft signs Neurological Evaluation Scale Psychomotor impairment Cognitive impairment 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Psychiatrie Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R), 3rd edn, revised. American Psychiatrie Press, Washington, DCGoogle Scholar
  2. Andreasen NC (1989) Scale for the Assessment of Negative Symptoms (SANS). Br J Psychiatry 155 (Suppl 7):53–58Google Scholar
  3. Andreasen NC, Olson S (1983) Negative vs positive schizophrenia. Definition and validation. Arch Gen Psychiatry 39:789–794Google Scholar
  4. Andreasen N, Rezai K, Alliger R, Swayze VW, Flaum M, Kirchner P, Cohen G, O'Lear (1992) Hypofrontality with Xenon-133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 49:943–958Google Scholar
  5. Andreasen NC (1982) Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry 39:784–788Google Scholar
  6. Bihari K, Pato MT, Hill JL, Murphy DL (1991) Neurologic soft signs in obsessive-compulsive disorder. Arch Gen Psychiatry 48:278–279Google Scholar
  7. Buchanan RW, Heinrichs DW (1989) The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological sign in schizophrenia. Psychiatry Res 27:335–350Google Scholar
  8. Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter WT (1990) Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry 147:290–294Google Scholar
  9. Carpenter WT, Heinrichs DW, Wagman AMI (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145:578–583Google Scholar
  10. Cox SM, Ludwig AM (1979) Neurological soft signs and psychophathology. Findings in schizophrenia. J Nerv Ment Dis 167: 161–165Google Scholar
  11. Crow TJ, Done DJ, Sacker A (1994) Neurological abnormality in children who develop psychosis in adulthood. Schizophr Res 11:96Google Scholar
  12. Fish B, Marcus J, Hans SL, Auerbach JG, Perdue S (1992) Infants at risk for schizophrenia? Sequelae of a genetic neurointegrative defect. Arch Gen Psychiatry 49:221–235Google Scholar
  13. Franz U, Fraaz S, Bender W, Cohen R, Mohr F, Wahlheim W (1992) CCT-Befunde bei schizophrenen Patienten-Psychopathologische und neurologische Korrelate. Fortschr Neurol Psychiatr 60:Sonderheft 2Google Scholar
  14. Gureje O (1988) Neurological soft signs in Nigerian schizophrenics: a controlled study. Acta Psychiatr Scand 78:505–509Google Scholar
  15. Heinrichs DW, Buchanan RW (1988) Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry 145:11–18Google Scholar
  16. Johnstone EC, Macmillan JF, Frith Cd, Benn DK, Crow TJ (1990) Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry 157:182–189Google Scholar
  17. Jung E, Krumm B, Biehl H, Maurer K, Bauer-Schubart C (1989) Mannheimer Skala zur Einschätzung von sozialer Behinderung. (DAS-M) Beltz, WeinheimGoogle Scholar
  18. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261–276Google Scholar
  19. Kay SR, Opler LA, Lindenmyer JP (1988) Reliability and validity of the Positive and Negative Syndrome Scale for schizophrenics. Psychiatry Res 23:99–110Google Scholar
  20. King DJ, Wilson A, Cooper SJ, Waddington JL (1991) The clinical correlates of neurological soft signs in chronic schizophrenia. Br J Psychiatry 158:770–775Google Scholar
  21. Kinney DK, Woods BT, Yurgelun-Todd D (1986) Neurologic abnormalities in schizophrenic patients and their families. Neurologic and psychiatric findings in relatives. Arch Gen Psychiatry 43:665–668Google Scholar
  22. Kinney DK, Yurgelun-Todd DA, Woods BT (1991) Hard neurologic signs and psychopathology in relatives of schizophrenic patients. Psychiatry Res 39:45–53Google Scholar
  23. Kolakowska T, Williams AO, Jambor K, Ardern M (1985) Schizophrenia with good an poor outcome. Neurological soft signs, cognitive impairment and their clinical significance. Br J Psychiatry 146:348–357Google Scholar
  24. Lewis DO, Pincus JH, Feldman M, Jackson MA, Bard B (1986) Psychiatric, neurological, and psychoeducational characteristics of 15 death row inmates in the United States. Am J Psychiatry 143:838–845Google Scholar
  25. Lukoff D, Nuechterlein KH, Ventura J (1986) Manual for the expanded Brief Psychiatric Rating Scale (BPRS). Schizophr Bull 12:594–602Google Scholar
  26. Luria AR (1966) Higher cortical functions in man. Basic Books, New YorkGoogle Scholar
  27. Manschreck TC, Ames D (1984) Neurologic features and psychopathology. Biol Psychiatry 19:703–719Google Scholar
  28. Marcus J, Hans SL, Lewow E, Wilkinson L, Burack CM (1985) Neurological findings in high-risk children: childhood assessment and 5-year follow-up. Schizophr Bull 11:85–100Google Scholar
  29. Meehl PE (1990) Toward an integrated theory of schizotaxia, schizotypy, and schizophrenia. J Personality Disord 4:1–99Google Scholar
  30. Merriam AE, Kay SR, Opler LA, Kushner SF, Praag HM van (1990) Neurological signs and the positive-negative dimension in schizophrenia. Biol Psychiatry 28:181–192Google Scholar
  31. Mohr F, Hubmann W, Bender W, Vaitl P, Holmes PE (1994) The Behavior Therapy Unit of the Bezirkskrankenhaus Haar. In: Liberman RP, Corrigan P (eds) Behavior therapy in psychiatric hospitals. Springer, Berlin Heidelberg New YorkGoogle Scholar
  32. Mosher LR, Pollin W, Stabenau JR (1971) Identical twins discordant for schizophrenia. Neurologic findings. Arch Gen Psychiatry 24:422–430Google Scholar
  33. Nasrallah HA, Tippin F, McCalley-Whitters M (1983) Neurological soft signs in manic patients: a comparison with schizophrenic and control groups. Arch Gen Psychiatry 5:45–50Google Scholar
  34. Nelson HE (1976) A modified card sorting test sensitive to frontal lobe defects. Cortex 12:601–614Google Scholar
  35. Nickoloff SE, Radant AD, Reichler R, Homer DW (1991) Smooth pursuit and saccadic eye movements and neurological soft signs in obsessive-compulsive disorder. Psychiatry Res 38:173–185Google Scholar
  36. Overall IR, Gorham DR (1962) Brief Psychiatric Rating Scale. Psychol Rep 10:799–812Google Scholar
  37. Petrides M, Milner B (1982) Deficits on subject-ordered tasks after frontal and temporal lobe lesions in man. Neuropsychologia 20:249–262Google Scholar
  38. Pollock B, Perel JM, Schulz S, Conley R, Stiller R (1986) Characteristics of non-responders to haloperidol (hal) treatment. Acta Pharmacol (Suppl 5, pt 1) 59:107Google Scholar
  39. Quitkin F, Rifkin A, Klein DF (1976) Neurologic soft signs in schizophrenia and character disorder. Arch Gen Psychiatry 33: 845–853Google Scholar
  40. Raven JL (1960) Guide to the Standard Progressive Matrices. LondonGoogle Scholar
  41. Research Branch (1975) Abnormal involuntary movement scale. Psychopharmacology 44:907–912Google Scholar
  42. Rossi A, Cataldo S de, Michele V di, Manna V, Ceccoli S, Stratta PC (1990) Neurological soft signs in schizophrenia. Br J Psychiatry 157:735–739Google Scholar
  43. Schlenker R, Cohen R, Berg P, Humbann W, Mohr F, Watzl H, Werther P (1994) Smooth-pursuit eye movement dysfunction in schizophrenia: the role of attention and general psychomotor dysfunctions. Eur Arch Psychiatry Clin Neurosci 244:153–160Google Scholar
  44. Schlenker R, Cohen R, Hubmann W, Mohr F, Wahlheim C, Watzl H, Werther P (1995) Electrodermal and vascular orientation response in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 245:152–158Google Scholar
  45. Schooler N, Kane JM (1982) Research diagnosis for tardive dyskinesia. Arch Gen Psychiatry 39:486–487Google Scholar
  46. Schröder J, Niethammer R, Geider FJ, Reitz Ch, Binkert M, Jauss M, Sauer H (1992a) Neurological soft signs in schizophrenia. Schizophr Res 6:25–30Google Scholar
  47. Schröder J, Geider FJ, Binkert M (1992b) Subsyndromes in chronic schizophrenia: Do their psychopathological characteristics correspond to cerebral alterations? Psychiatry Res 42 (3):209–220Google Scholar
  48. Schröder J, Niethammer R, Geider FL, Binkert M, Reitz Ch, Jauss M, Richter P, Sauer H (1993) Neurologische Soft Signs bei endogenen Psychosen. In: Baumann P (ed) Biologische Psychiatrie der Gegenwart. Springer, Berlin, Heidelberg New YorkGoogle Scholar
  49. Shaffer D, O'Connor P, Shafer SQ, Prupis S (1983) Neurological “soft signs”: their origins and significance for behavior. In: Rutter M (ed) Developmental neuropsychiatry New York, Guilford Press, pp 144–163Google Scholar
  50. Shallice T (1982) Specific impairments on planning. Phil Trans R Soc Lond B298:199–209Google Scholar
  51. Simpson GH, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand (Suppl) 212:11–19Google Scholar
  52. Strauss JS, Carpenter WT (1974) Thearediction of outcome in schizophrenieprediction: II. Relationship between predictors and outcome variables. Arch Gen Psychiatry 31:37–42Google Scholar
  53. Torrey EF (1980) Neurological abnormalities in schizophrenic patients. Biol Psychiatry 15 (3):381–388Google Scholar
  54. Tucker GJ, Champion EW, Silberfarb BM (1975) Sensorimotor functions and cognitive disturbance in psychiatric patients. Am J Psychiatry 132 (1):17–21Google Scholar
  55. Walker E, Shaye J (1982) Familial schizophrenia. A predictor of neuromotor and attentional abnormalities in schizophrenia. Arch Gen Psychiatry 39:1153–1156Google Scholar
  56. Wegner JT, Catalano F, Gibralter J, Kane JM (1985) Schizophrenics with tardive dyskinesia. Arch Gen Psychiatry 42:860–865Google Scholar
  57. Weigl (1941) On the psychologiy of so-called processes of abstraction. J Anorm Soc Psychol 36:3–33Google Scholar
  58. Weinberger DR, Wyatt RJ (1982) Cerebral ventricular size: a biological marker for subtyping chronic schizophrenia. In: Usdin E, Hanin I (eds) Biological markers in psychiatry and neurology. Pergamon Press, New York, pp 505–512Google Scholar
  59. Weinberger RD, Berman KF, Zec R (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry 43:114–124Google Scholar
  60. Weinberger DR, Berman KF, Illowsky BP (1988) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. A new cohort. Arch Gen Psychiatry 45:609–615Google Scholar
  61. Wing JL, Cooper J, Sartorius N (1973) The Present State Examination (PSE). Medical Research Council, Cambridge University Press, LondonGoogle Scholar
  62. Woods BT, Kinney DK, Yurgelun-Todd D (1986) Neurological anormalities in schizophrenic patients and their families. Arch Gen Psychiatry 43:657–663Google Scholar
  63. World Health Organization (1988) Psychiatric Disability Assessment Schedule. WHO, GenevaGoogle Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • F. Mohr
    • 1
  • W. Hubmann
    • 1
  • W. Bender
    • 1
  • S. Hönicke
    • 1
  • Ch. Wahlheim
    • 1
  • R. Cohen
    • 2
  • C. Haslacher
    • 2
  • R. Schlenker
    • 2
  • P. Werther
    • 2
  1. 1.Hospital HaarHaarGermany
  2. 2.Department of PsychologyUniversity of KonstanzKonstanzGermany

Personalised recommendations